Diabetes mellitus and the risk of progression or malignancy of pancreatic cystic neoplasms in patients undergoing surveillance: A systematic review and meta-analysis
- 4 October 2022
- journal article
- research article
- Published by Elsevier in Pancreatology
- Vol. 22 (8) , 1195-1201
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinomaPancreatology, 2017
- Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreasPancreatology, 2017
- Risk factors for malignant progression of intraductal papillary mucinous neoplasmsDigestive and Liver Disease, 2015
- American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic CystsGastroenterology, 2015
- Biliary Findings Assist in Predicting Enlargement of Intraductal Papillary Mucinous Neoplasms of the PancreasClinical Gastroenterology and Hepatology, 2013
- Asymptomatic Pancreatic Cystic Neoplasms: Maximizing Survival and Quality of Life Using Markov-Based Clinical NomogramsGastroenterology, 2010
- Branch duct intraductal papillary mucinous neoplasms in a retrospective series of 190 patientsBritish Journal of Surgery, 2009
- Pancreatic Cancer–Associated Diabetes Mellitus: Prevalence and Temporal Association With Diagnosis of CancerGastroenterology, 2008
- Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studiesBritish Journal of Cancer, 2005
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000